ATI RN
Cardiovascular System Exam Questions And Answers
1. The client is given an alpha agonist. What might it be used for?
- A. For hemostasis
- B. To dilate the arteries
- C. To dilate the veins
- D. To decrease afterload
Correct answer: A
Rationale: Alpha agonists are used for hemostasis to help control bleeding by constricting blood vessels, leading to decreased blood flow to the area. Choices B, C, and D are incorrect as alpha agonists do not typically dilate arteries, dilate veins, or decrease afterload.
2. The client on digoxin has a potassium level of 3.0 mEq/L. What is the nurse’s priority action?
- A. Administer a potassium supplement
- B. Hold the digoxin and notify the healthcare provider
- C. Continue the current digoxin dose
- D. Administer Digibind
Correct answer: B
Rationale: The correct answer is to hold the digoxin and notify the healthcare provider. A potassium level of 3.0 mEq/L indicates hypokalemia, which can increase the risk of digoxin toxicity. Digoxin and low potassium levels can lead to serious cardiac arrhythmias. Administering a potassium supplement (choice A) without healthcare provider guidance can worsen the situation. Continuing the current digoxin dose (choice C) can further increase the risk of toxicity. Administering Digibind (choice D) is used in severe cases of digoxin toxicity, not for addressing low potassium levels.
3. This is a type of lung disease that results from the inhalation of certain dusts, often in the workplace, leading to lung damage.
- A. Pneumoconiosis
- B. Asbestosis
- C. Silicosis
- D. Anthracosis
Correct answer: A
Rationale: Pneumoconiosis is the correct answer. It is a lung disease caused by inhaling certain types of dust, commonly in a workplace setting, resulting in lung damage. Asbestosis (choice B) is a specific type of pneumoconiosis caused by asbestos fibers. Silicosis (choice C) is another type of pneumoconiosis caused by inhaling crystalline silica dust. Anthracosis (choice D) is a condition characterized by the accumulation of coal dust particles in the lungs, not necessarily resulting in lung damage.
4. Which condition is characterized by the lungs becoming scarred and stiff, leading to difficulty breathing and inadequate oxygen intake into the bloodstream?
- A. Pulmonary fibrosis
- B. Cystic fibrosis
- C. COPD
- D. Tuberculosis
Correct answer: A
Rationale: The correct answer is A, Pulmonary fibrosis. Pulmonary fibrosis is a lung disease where lung tissue is damaged and scarred, resulting in breathing difficulties and decreased oxygen transfer into the bloodstream. Cystic fibrosis (B) is a genetic disorder primarily affecting the lungs and digestive system, not causing lung scarring. COPD (C) includes conditions like chronic bronchitis and emphysema but doesn't specifically involve lung scarring. Tuberculosis (D) is a bacterial infection that primarily affects the lungs but doesn't cause lung tissue scarring and stiffness as seen in pulmonary fibrosis.
5. Which medication is used to lower high blood pressure and reduce the risk of heart attacks and strokes?
- A. ACE inhibitor
- B. Beta-blocker
- C. Diuretic
- D. Calcium channel blocker
Correct answer: A
Rationale: The correct answer is an ACE inhibitor. ACE inhibitors are medications specifically designed to lower high blood pressure and reduce the risk of heart attacks, strokes, and other cardiovascular events. Beta-blockers, diuretics, and calcium channel blockers are also used to treat high blood pressure, but ACE inhibitors are particularly effective in reducing the risk of heart attacks and strokes.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access